Open Access Journals gaining more Readers and Citations
700 Journals and 15,000,000 Readers Each Journal is getting 25,000+ Readers
John Koren is a research scholar from Sloan-Kettering Cancer Centre. He is examining the mechanisms which allow some cancer-cell models to survive following Hsp90 inhibition. These studies cover cancer biology, basic Hsp90 biochemistry, signal transduction, and pharmacology. He is also studying the effects of a unique blood-brain barrier permeable Hsp90 inhibitor as a therapeutic option for neurodegenerative diseases. These studies include neurobiology, animal behavior analysis, and basic neural-biochemistry.
Neurodegenerative Diseases, Alzheimer’s Research, Cancer Biology, Molecular Neurobiology, Molecular Medicine
Aaron Carman, Sarah Kishinevsky, John Koren III , Wenjie Lou and Gabriela Chiosis
Review Article: J Alzheimers Dis Parkinsonism 2013, S10-005
Aaron Carman, Sarah Kishinevsky, John Koren III, Wenjie Lou and Gabriela Chiosis
Review Article: J Alzheimers Dis Parkinsonism 2013, S10-007